These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 20628121)
1. Some suggest wider therapeutic window for offering alteplase to treat stroke. Mitka M JAMA; 2010 Jul; 304(2):146. PubMed ID: 20628121 [No Abstract] [Full Text] [Related]
2. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window? Parsons MW Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346 [No Abstract] [Full Text] [Related]
4. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Shobha N; Buchan AM; Hill MD; Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345 [TBL] [Abstract][Full Text] [Related]
5. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke. Kappelle LJ; de Borst GJ Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971 [No Abstract] [Full Text] [Related]
6. Recurrent ischemic stroke can happen in stroke patients very early after intravenous thrombolysis. Kamal H; Mowla A; Farooq S; Shirani P J Neurol Sci; 2015 Nov; 358(1-2):496-7. PubMed ID: 26375625 [No Abstract] [Full Text] [Related]
7. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients. Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979 [No Abstract] [Full Text] [Related]
11. Alteplase beyond three hours in ischemic stroke: do we know enough? Jawaid A; Fitch O; Qureshi S; Wilson AM; Schulz PE Int J Stroke; 2009 Apr; 4(2):70. PubMed ID: 19383044 [No Abstract] [Full Text] [Related]
12. Comment on "Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke". Ahmad A; Sharma VK J Clin Neurosci; 2011 Jan; 18(1):160-1; author reply 161. PubMed ID: 20932764 [No Abstract] [Full Text] [Related]
13. Role of tissue plasminogen activator in acute ischemic stroke. Hatcher MA; Starr JA Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027 [TBL] [Abstract][Full Text] [Related]
14. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan. Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704 [TBL] [Abstract][Full Text] [Related]
15. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke. Zhang B; Sun XJ; Ju CH Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577 [TBL] [Abstract][Full Text] [Related]
16. Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase. Chester KW; Corrigan M; Schoeffler JM; Shah M; Toy F; Purdon B; Dillon GM Expert Opin Drug Saf; 2019 Feb; 18(2):87-96. PubMed ID: 30712409 [TBL] [Abstract][Full Text] [Related]
18. Bolus-to-Infusion Time in Stroke Patients Treated with Alteplase on the CT Table: A Clinical Concern. Iglesias Mohedano AM; García Pastor A; de Lorenzo Pinto A; Gil Núñez AC Cerebrovasc Dis; 2019; 48(1-2):96-98. PubMed ID: 31593952 [No Abstract] [Full Text] [Related]
19. Thrombolysis 3 to 4.5 hours after acute ischemic stroke. Morris DC N Engl J Med; 2008 Dec; 359(26):2841; author reply 2841. PubMed ID: 19115492 [No Abstract] [Full Text] [Related]